2022. Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), 458–462. DOI:https://doi.org/10.25251/skin.6.6.2.